Literature DB >> 21665206

Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus.

Douwe J Mulder1, Jan Freark de Boer, Reindert Graaff, Rindert de Vries, Wijtske Annema, Joop D Lefrandt, Andries J Smit, Uwe J F Tietge, Robin P F Dullaart.   

Abstract

OBJECTIVE: High density lipoprotein (HDL) particles protect apolipoprotein B-containing lipoproteins from oxidative modification. An impaired anti-oxidative functionality of HDL in type 2 diabetes mellitus (T2DM) may contribute to enhanced formation of oxidative stress products, such as Advanced Glycation Endproducts (AGEs). We tested whether in T2DM the HDL anti-oxidative capacity is related to the accumulation of AGEs in the skin.
METHODS: Skin autofluorescence (AF), a non-invasive read-out for AGEs, and HDL anti-oxidative capacity, i.e. the ability of HDL to protect against LDL oxidation in vitro, were assessed in 67 non-smoking T2DM patients without complications (median age: 60 (53-65), 60% males, 6.5 (5.2-8.5) years of diabetes duration).
RESULTS: In univariate analysis, skin AF correlated inversely with HDL anti-oxidative capacity (r=-0.305, P<0.02), but not with HDL cholesterol or apolipoprotein A-I. HDL anti-oxidative capacity correlated inversely with glucose, HbA(1c), triglycerides, and insulin resistance (homeostasis model assessment) (P<0.05 to P ≤ 0.001). Multiple linear regression showed that skin AF remained inversely related to HDL anti-oxidative capacity (partial r=-0.314, P=0.015) taking account of age, plasma glucose, non-HDL cholesterol, triglycerides, HOMA(ir), and CRP.
CONCLUSION: These findings suggest that skin AF is inversely related to the HDL anti-oxidative capacity rather than to the HDL cholesterol concentration in T2DM. Impaired anti-oxidative functionality of HDL could contribute to tissue accumulation of AGEs.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21665206     DOI: 10.1016/j.atherosclerosis.2011.05.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.

Authors:  Wijtske Annema; Arne Dikkers; Jan Freark de Boer; Robin P F Dullaart; Jan-Stephan F Sanders; Stephan J L Bakker; Uwe J F Tietge
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 2.  Unlocking the biology of RAGE in diabetic microvascular complications.

Authors:  Michaele B Manigrasso; Judyta Juranek; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Trends Endocrinol Metab       Date:  2013-09-03       Impact factor: 12.015

3.  Skin autofluorescence, 5-year mortality, and cardiovascular events in peripheral arterial disease: all that glitters is surely not gold.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-04       Impact factor: 8.311

Review 4.  Low-normal thyroid function and novel cardiometabolic biomarkers.

Authors:  Lynnda J N van Tienhoven-Wind; Robin P F Dullaart
Journal:  Nutrients       Date:  2015-02-16       Impact factor: 5.717

5.  Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.

Authors:  Khai P Ng; Stephanie J Stringer; Mark D Jesky; Punit Yadav; Rajbir Athwal; Mary Dutton; Charles J Ferro; Paul Cockwell
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

6.  Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components.

Authors:  Robert P van Waateringe; Sandra N Slagter; Andre P van Beek; Melanie M van der Klauw; Jana V van Vliet-Ostaptchouk; Reindert Graaff; Andrew D Paterson; Helen L Lutgers; Bruce H R Wolffenbuttel
Journal:  Diabetol Metab Syndr       Date:  2017-05-30       Impact factor: 3.320

7.  Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis.

Authors:  Sho-Ichi Yamagishi; Takanori Matsui
Journal:  Ann Vasc Dis       Date:  2018-09-25

8.  ApoA-I Mimetic Peptide Reduces Vascular and White Matter Damage After Stroke in Type-2 Diabetic Mice.

Authors:  Xiaohui Wang; Rongwen Li; Alex Zacharek; Julie Landschoot-Ward; Michael Chopp; Jieli Chen; Xu Cui
Journal:  Front Neurosci       Date:  2019-10-25       Impact factor: 4.677

9.  Role of Src in Vascular Hyperpermeability Induced by Advanced Glycation End Products.

Authors:  Weijin Zhang; Qiulin Xu; Jie Wu; Xiaoyan Zhou; Jie Weng; Jing Xu; Weiju Wang; Qiaobing Huang; Xiaohua Guo
Journal:  Sci Rep       Date:  2015-09-18       Impact factor: 4.379

10.  A new in vivo model using a dorsal skinfold chamber to investigate microcirculation and angiogenesis in diabetic wounds.

Authors:  Stefan Langer; Christian Beescho; Andrej Ring; Olivia Dorfmann; Hans Ulrich Steinau; Nick Spindler
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.